Opiant Pharmaceuticals Secures $50 Million in Convertible Debt Financing
December 11, 2020, 1:38 am
Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ:OPNT), a specialty pharmaceutical company developing medicines to
Curated, Global, Hometown News for the City and Citizens of Santa Monica California
Opiant Pharmaceuticals Secures $50 Million in Convertible Debt Financing
COPYRIGHT © Indian Hill Media Inc. Another Smiling Dog Web Development. Hosted by InlandEmpire.IO ALL RIGHTS RESERVED.
COPYRIGHT © Indian Hill Media Inc. Another Smiling Dow Web Development. Hosted by InlandEmpire.IO ALL RIGHTS RESERVED.
